Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by bigdog343on Jan 28, 2020 10:32am

134 Views

Post# 30608422

RE:Bargain prices on shares today

88guy88 wrote: really cheap now.....good buying point.....huge potential with this stock

How low do you expect this to drop to ? Seems we could be months away from news that investors will like.

Actually I would not mind seeing this back down into the 1.50 range again . Thats a bargain. lol thanks.

Bullboard Posts

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!